The most common conditions

Title Effect Research Type Journal Year
Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis. positive animals European journal of pharmacology 2004
A comparative analysis of the potential of cannabinoids and ondansetron to suppress cisplatin-induced emesis in the Suncus murinus (house musk shrew). positive animals Psychopharmacology 2004
Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew). positive animals Psychopharmacology 2004
Effects of cannabinoids on lithium-induced conditioned rejection reactions in a rat model of nausea. positive animals Psychopharmacology 2003
Intravenous Delta-9-Tetrahydrocannabinol to Prevent Postoperative Nausea and Vomiting: A Randomized Controlled Trial. NONE humans Anesthesia and analgesia 2015
Delta-9-tetrahydrocannabinol interferes with the establishment and the expression of conditioned rejection reactions produced by cyclophosphamide: a rat model of nausea. positive animals Neuroreport 1999
Delta-9-tetrahydrocannabinol delays the gastric emptying of solid food in humans: a double-blind, randomized study. positive humans Alimentary pharmacology & therapeutics 1999
Cannabis and cancer chemotherapy: a comparison of oral delta-9-THC and prochlorperazine. positive humans Cancer 1982
Antiemetic effect of delta 9-tetrahydrocannabinol in chemotherapy-associated nausea and emesis as compared to placebo and compazine. positive humans Journal of clinical pharmacology 1981
A prospective evaluation of delta-9-tetrahydrocannabinol as an antiemetic in patients receiving adriamycin and cytoxan chemotherapy. NONE humans Cancer 1981
Antiemetic effect of tetrahydrocannabinol. Compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis. positive humans Archives of internal medicine 1980
delta 9-Tetrahydrocannabinol for refractory vomiting induced by cancer chemotherapy. positive humans JAMA 1980
Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapy. positive humans Investigational new drugs 1988
Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo. positive humans Annals of internal medicine 1979
delta 9-Tetrahydrocannabinol (THC) as an antiemetic in patients treated with cancerchemotherapy; a double-blind cross-over trial against placebo. positive humans Veterinary and human toxicology 1979
Delata-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation. positive humans Annals of internal medicine 1979
Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ(9) -tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats. positive animals British journal of pharmacology 2013
Title Effect Research Type Journal Year
Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinus. positive animals British journal of pharmacology 2013